Sector ratings Bio-Rad Laboratories, Inc. NYSE

Stocks

Market Closed - NYSE 00:10:00 21/08/2026 +04			5-day change	1st Jan Change
365.08 ^USD	+8.33%		+8.33%	+17.50%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
ABBOTT LABORATORIES	197B	BBB
MEDTRONIC PLC	118B	BBB
CENCORA, INC.	62.55B	AA
HOYA CORPORATION	52.4B	AAA
BECTON, DICKINSON AND COMPANY	51.81B	A
DEXCOM, INC.	33.57B	BBB
MEDLINE INC.	30.34B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.63B	AA
TERUMO CORPORATION	23.81B	AA
STERIS PLC	23.09B	AAA	-
SARTORIUS STEDIM BIOTECH	21.77B	BBB
ZIMMER BIOMET HOLDINGS, INC.	19.34B	A
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.57B	A
SOLVENTUM CORPORATION	15.58B	BBB
BAXTER INTERNATIONAL INC.	13.7B	A
ALIGN TECHNOLOGY, INC.	11.31B	A
GLOBUS MEDICAL, INC.	11.16B	CCC
BIO-RAD LABORATORIES, INC.	10.27B	BBB	-
REPLIGEN CORPORATION	10.18B	AA
Average	39.28B	A
Weighted average by Cap.		A